Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001666071-21-000173
Filing Date
2021-09-03
Accepted
2021-09-03 19:55:10
Documents
1
Period of Report
2021-09-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_163071329274796.html 4  
1 FORM 4 wf-form4_163071329274796.xml 4 8282
  Complete submission text file 0001666071-21-000173.txt   9723
Mailing Address CARDLYTICS, INC. 675 PONCE DE LEON AVENUE NE, SUITE 6000 ATLANTA GA 30308
Business Address
Grimes Scott D. (Reporting) CIK: 0001617486 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38386 | Film No.: 211237956

Mailing Address 675 PONCE DE LEON AVENUE, NE SUITE 6000 ATLANTA GA 30308
Business Address 675 PONCE DE LEON AVENUE, NE SUITE 6000 ATLANTA GA 30308 888-798-5802
Cardlytics, Inc. (Issuer) CIK: 0001666071 (see all company filings)

EIN.: 263039436 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 7370 Services-Computer Programming, Data Processing, Etc.